Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03219411 · ClinicalTrials.gov registry record · Phase 2
Effects of Cinnamon Supplementation on Glucose Metabolism in Patients With Pre-diabetes
A Phase 2 study, sponsored by Joslin Diabetes Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
NCT03219411 is a Phase 2 study that has completed, run by Joslin Diabetes Center. The registered enrollment target is 12 participants.
The verdict
NCT03219411, a Phase 2 study, has completed, sponsored by Joslin Diabetes Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
Study Summary
The transition from normal glucose tolerance to overt type 2 diabetes mellitus (T2D) encompasses a variety of glycemic abnormalities that are commonly referred to as 'prediabetes'. While intensive lifestyle interventions are the cornerstone of T2D prevention, developing safe, cost-effective adjunct therapeutic strategies is a clinically relevant goal. Cinnamon supplementation has been shown to improve fasting plasma glucose in patients with T2D. This placebo-controlled, randomized study will determine if cinnamon improves glucose homeostasis in patients with prediabetes over a 12-week period.
Interventions
- OTHER placebo
- DIETARY_SUPPLEMENT Cinnamon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-08-28 |
| Est. Completion | 2019-07-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03219411
The ClinicalTrials.gov registry entry for NCT03219411 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT03219411 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03219411 about?
NCT03219411 is a clinical study titled "Effects of Cinnamon Supplementation on Glucose Metabolism in Patients With Pre-diabetes". The transition from normal glucose tolerance to overt type 2 diabetes mellitus (T2D) encompasses a variety of glycemic abnormalities that are commonly referred to as 'prediabetes'. While intensive lifestyle interventions are the cornerstone of T2D prevention, developing safe, cost-effective adjunct ...
What is the current status of trial NCT03219411?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2017-08-28. Estimated completion is 2019-07-30.
What interventions are being tested in trial NCT03219411?
The interventions under investigation include: placebo (OTHER), Cinnamon (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03219411?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.